1. Home
  2. MRSN
  3. MRSN News

Latest Mersana Therapeutics Inc. (MRSN) News on July 7, 2025

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
MRSN

GlobeNewswire

a month ago

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting

Mersana Therapeutics to Present at Upcoming Investor Conferences
MRSN

GlobeNewswire

2 months ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

MRSN

MT Newswires

2 months ago

Truist Raises Price Target on Mersana Therapeutics to $10 From $9, Keeps Buy Rating

Mersana Therapeutics Inc (MRSN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...
MRSN

GuruFocus.com

2 months ago

Mersana Therapeutics Inc (MRSN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...

MRSN

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Mersana Therapeutics Inc Earnings Call

CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
MRSN

GlobeNewswire

2 months ago

CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates
MRSN

Zacks

2 months ago

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
MRSN

GlobeNewswire

2 months ago

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Mersana Therapeutics Inc (MRSN) Q1 2025 Earnings Report Preview: What to Look For
MRSN

GuruFocus.com

2 months ago

Mersana Therapeutics Inc (MRSN) Q1 2025 Earnings Report Preview: What to Look For

MRSN

MT Newswires

2 months ago

Wedbush Cuts Price Target on Mersana Therapeutics to $3 From $4, Maintains Outperform Rating

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer
MRSN

GlobeNewswire

2 months ago

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer

Bluebird pleads for deal support; Unity, Mersana lay off staff
MRSN

BioPharma Dive

2 months ago

Bluebird pleads for deal support; Unity, Mersana lay off staff

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
MRSN

GlobeNewswire

2 months ago

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MRSN

GlobeNewswire

3 months ago

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
MRSN

GlobeNewswire

3 months ago

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

Earnings Update: Mersana Therapeutics, Inc. (NASDAQ:MRSN) Just Reported And Analysts Are Boosting Their Estimates
MRSN

Simply Wall St.

4 months ago

Earnings Update: Mersana Therapeutics, Inc. (NASDAQ:MRSN) Just Reported And Analysts Are Boosting Their Estimates

Industry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts
MRSN

Simply Wall St.

4 months ago

Industry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts

Mersana Therapeutics Full Year 2024 Earnings: Beats Expectations
MRSN

Simply Wall St.

4 months ago

Mersana Therapeutics Full Year 2024 Earnings: Beats Expectations

Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings Call Highlights: Strategic Advances and ...
MRSN

GuruFocus.com

4 months ago

Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

MRSN

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Mersana Therapeutics Inc Earnings Call

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates
MRSN

Zacks

4 months ago

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
MRSN

GlobeNewswire

4 months ago

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results

What To Expect From Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings
MRSN

GuruFocus.com

4 months ago

What To Expect From Mersana Therapeutics Inc (MRSN) Q4 2024 Earnings

Mersana Therapeutics to Present at Upcoming Investor Conferences
MRSN

GlobeNewswire

4 months ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025
MRSN

GlobeNewswire

4 months ago

Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MRSN

GlobeNewswire

5 months ago

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MRSN

MT Newswires

5 months ago

William Blair Initiates Coverage on Mersana Therapeutics With Outperform Rating

Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
MRSN

GlobeNewswire

5 months ago

Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

MRSN

MT Newswires

6 months ago

Wedbush Cuts Price Target on Mersana Therapeutics to $4 From $7, Keeps Outperform Rating

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
MRSN

Benzinga

6 months ago

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?

MRSN

MT Newswires

6 months ago

Mersana Therapeutics' XMT-1660 Gains Additional US FDA Fast Track Designation

MRSN

MT Newswires

6 months ago

Mersana Therapeutics Says Initial Data From Cancer Drug Trial Shows Promise, Shares Rise Premarket

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
MRSN

GlobeNewswire

6 months ago

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer
MRSN

GlobeNewswire

6 months ago

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
MRSN

GuruFocus.com

8 months ago

Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

MRSN

Thomson Reuters StreetEvents

8 months ago

Q3 2024 Mersana Therapeutics Inc Earnings Call

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates
MRSN

Zacks

8 months ago

Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
MRSN

GlobeNewswire

8 months ago

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024
MRSN

GlobeNewswire

8 months ago

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc
MRSN

GuruFocus.com

9 months ago

SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
MRSN

Simply Wall St.

a year ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates
MRSN

Zacks

a year ago

Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

Mersana Therapeutics (NASDAQ:MRSN) shareholders have endured a 83% loss from investing in the stock three years ago
MRSN

Simply Wall St.

a year ago

Mersana Therapeutics (NASDAQ:MRSN) shareholders have endured a 83% loss from investing in the stock three years ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
MRSN

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

MRSN

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
MRSN

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

MRSN

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
MRSN

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
MRSN

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
MRSN

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
MRSN

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
MRSN

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
MRSN

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
MRSN

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
MRSN

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
MRSN

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
MRSN

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed
MRSN

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
MRSN

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

See's Candies® Launches New Scotchmallow® Littles
MRSN

PR Newswire

a year ago

See's Candies® Launches New Scotchmallow® Littles

Stock futures slip as markets digest hot jobs data
MRSN

Yahoo Finance Video

a year ago

Stock futures slip as markets digest hot jobs data

SOUTHWEST AIRLINES RANKED TOP AIRLINE ON FORBES AMERICA'S BEST EMPLOYERS FOR VETERANS LIST
MRSN

PR Newswire

a year ago

SOUTHWEST AIRLINES RANKED TOP AIRLINE ON FORBES AMERICA'S BEST EMPLOYERS FOR VETERANS LIST

IBHS honors resilient construction trailblazers
MRSN

PR Newswire

a year ago

IBHS honors resilient construction trailblazers

Lyft Stock Rides High On Bullish Double-Upgrade After Company Offers New Growth Targets
MRSN

Investor's Business Daily

a year ago

Lyft Stock Rides High On Bullish Double-Upgrade After Company Offers New Growth Targets

MRSN

Benzinga

a year ago

Bill Gates Could Be The World's First Trillionaire If He Had 'Diamond Handed' His Microsoft Shares — He'd Be Sitting On $1.47 Trillion Today

Kohler Mira Ltd. Celebrates Mental Health Awareness Week in the UK: Promoting Wellbeing and Sharing Healthy Habits
MRSN

ACCESSWIRE

a year ago

Kohler Mira Ltd. Celebrates Mental Health Awareness Week in the UK: Promoting Wellbeing and Sharing Healthy Habits

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.
MRSN

ACCESSWIRE

a year ago

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.

Mersana Therapeutics to Present at Upcoming Investor Conferences
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
MRSN

Simply Wall St.

a year ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript
MRSN

Insider Monkey

a year ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript

MRSN

GuruFocus.com

a year ago

Mersana Therapeutics Inc (MRSN) Reports Q1 2024 Financial Results: A Detailed Analysis

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates
MRSN

Zacks

a year ago

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates

Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
MRSN

Zacks

a year ago

Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript
MRSN

Insider Monkey

a year ago

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript

An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued
MRSN

Simply Wall St.

a year ago

An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued

Mersana Therapeutics Full Year 2023 Earnings: Revenues Disappoint
MRSN

Simply Wall St.

a year ago

Mersana Therapeutics Full Year 2023 Earnings: Revenues Disappoint

MRSN

Thomson Reuters StreetEvents

a year ago

Q4 2023 Mersana Therapeutics Inc Earnings Call

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates
MRSN

Zacks

a year ago

Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates

Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results
MRSN

GuruFocus.com

a year ago

Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Mersana Therapeutics to Present at Upcoming Investor Conferences
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?
MRSN

Zacks

a year ago

Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Should You Buy?

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

Mersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
MRSN

Zacks

a year ago

Mersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

5 Value Stock Buying Opportunities
MRSN

Zacks

a year ago

5 Value Stock Buying Opportunities

Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
MRSN

GlobeNewswire

a year ago

Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference

Is 2024 the Year for Utilities Stocks? 3 Top Sector Picks
MRSN

InvestorPlace

a year ago

Is 2024 the Year for Utilities Stocks? 3 Top Sector Picks

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?
MRSN

Simply Wall St.

a year ago

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?

Isabeau Levito edges Amber Glenn in figure skating nationals short program
MRSN

NBC Sports

a year ago

Isabeau Levito edges Amber Glenn in figure skating nationals short program

Independent Bank Corporation Reports 2023 Fourth Quarter Results
MRSN

GlobeNewswire

a year ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

The past five years for Oil States International (NYSE:OIS) investors has not been profitable
MRSN

Simply Wall St.

a year ago

The past five years for Oil States International (NYSE:OIS) investors has not been profitable

BlackBerry Stock Is Tumbling Tuesday: What's Going On?
MRSN

Benzinga

a year ago

BlackBerry Stock Is Tumbling Tuesday: What's Going On?

NGL Energy Partners LP Announces $2.1 Billion Offering of Senior Secured Notes
MRSN

Business Wire

a year ago

NGL Energy Partners LP Announces $2.1 Billion Offering of Senior Secured Notes

11 Best MLP Dividend Stocks To Buy
MRSN

Insider Monkey

a year ago

11 Best MLP Dividend Stocks To Buy

Share on Social Networks: